Novo Nordisk A/S
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Denmark
- Registered address
- Novo Alle 1, Bagsvaerd, Hovedstaden 2880, Denmark (DNK)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 3000151819 · DUNS 305914798
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-03-29
- VAIDrug Quality Assurance2019-12-05
- NAIBlood and Blood Products2018-05-18
- NAIDrug Quality Assurance2018-05-18
- VAIBlood and Blood Products2017-02-08
- NAIDrug Quality Assurance2016-04-08
- VAIDrug Quality Assurance2013-09-03
- OAIDrug Quality Assurance2012-03-20
- NAIBioresearch Monitoring2009-05-13
- NAIDrug Quality Assurance2009-03-06
Drugs this plant is listed as making
2 distinct drugs across 4 products name this site in their FDA label.
- liraglutidein shortageNovo Nordisk
- semaglutideNovo Nordisk Pharmaceutical Industries, LP
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.